Log in

NASDAQ:LFVNLifeVantage Stock Price, Forecast & News

$14.14
+0.56 (+4.12 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$13.73
Now: $14.14
$14.16
50-Day Range
$12.21
MA: $14.51
$15.89
52-Week Range
$7.75
Now: $14.14
$17.25
Volume47,900 shs
Average Volume100,863 shs
Market Capitalization$202.39 million
P/E Ratio17.90
Dividend YieldN/A
Beta1.36
LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs. It also provides skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, and micro-lift serums; and Hair Care System under the TrueScience brand name. The company sells its products through a direct sales model, as well as a network of independent distributors in the United States, Japan, Hong Kong, Australia, Canada, Mexico, Thailand, the United Kingdom, the Netherlands, Germany, Spain, and Taiwan. LifeVantage Corporation is headquartered in Sandy, Utah.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.87 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:LFVN
CUSIPN/A
Phone801-432-9000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$225.96 million
Cash Flow$0.79 per share
Book Value$1.90 per share

Profitability

Net Income$7.43 million

Miscellaneous

Employees220
Market Cap$202.39 million
Next Earnings Date8/12/2020 (Estimated)
OptionableOptionable

Receive LFVN News and Ratings via Email

Sign-up to receive the latest news and ratings for LFVN and its competitors with MarketBeat's FREE daily newsletter.

LifeVantage (NASDAQ:LFVN) Frequently Asked Questions

How has LifeVantage's stock been impacted by COVID-19 (Coronavirus)?

LifeVantage's stock was trading at $11.34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, LFVN stock has increased by 24.7% and is now trading at $14.14. View which stocks have been most impacted by Coronavirus.

When is LifeVantage's next earnings date?

LifeVantage is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for LifeVantage.

How were LifeVantage's earnings last quarter?

LifeVantage Corp (NASDAQ:LFVN) issued its earnings results on Tuesday, May, 5th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.16 by $0.03. The firm had revenue of $56.08 million for the quarter. LifeVantage had a return on equity of 43.08% and a net margin of 5.06%. View LifeVantage's earnings history.

What guidance has LifeVantage issued on next quarter's earnings?

LifeVantage issued an update on its FY 2020 After-Hours earnings guidance on Tuesday, May, 5th. The company provided earnings per share guidance of 0.74-0.79 for the period, compared to the Thomson Reuters consensus estimate of $0.79. The company issued revenue guidance of $235 million, compared to the consensus revenue estimate of $239.57 million.

Has LifeVantage been receiving favorable news coverage?

Media coverage about LFVN stock has been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. LifeVantage earned a media sentiment score of 0.7 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about LifeVantage.

Who are some of LifeVantage's key competitors?

What other stocks do shareholders of LifeVantage own?

Who are LifeVantage's key executives?

LifeVantage's management team includes the following people:
  • Mr. Darren Jay Jensen, Pres, CEO & Director (Age 50)
  • Mr. Steven R. Fife, Chief Financial Officer (Age 58)
  • Mr. Charles J. Wach, Chief Operating Officer (Age 57)
  • Mr. Kevin McMurray, Gen. Counsel
  • Mr. Ryan Goodwin, Chief Marketing Officer (Age 42)

What is LifeVantage's stock symbol?

LifeVantage trades on the NASDAQ under the ticker symbol "LFVN."

How do I buy shares of LifeVantage?

Shares of LFVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is LifeVantage's stock price today?

One share of LFVN stock can currently be purchased for approximately $14.14.

How big of a company is LifeVantage?

LifeVantage has a market capitalization of $202.39 million and generates $225.96 million in revenue each year. The company earns $7.43 million in net income (profit) each year or $0.59 on an earnings per share basis. LifeVantage employs 220 workers across the globe.

What is LifeVantage's official website?

The official website for LifeVantage is www.lifevantage.com.

How can I contact LifeVantage?

LifeVantage's mailing address is 9785 S. MONROE STREET SUITE 400, SANDY UT, 84070. The company can be reached via phone at 801-432-9000 or via email at [email protected]

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.